• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ki67和p53免疫组织化学减少了观察者间在巴雷特食管评估中的差异。

Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus.

作者信息

Lörinc E, Jakobsson B, Landberg G, Veress B

机构信息

Division of Pathology, Department of Clinical Pathology and Cytology, University Hospital MAS, Malmö, Sweden.

出版信息

Histopathology. 2005 Jun;46(6):642-8. doi: 10.1111/j.1365-2559.2005.02139.x.

DOI:10.1111/j.1365-2559.2005.02139.x
PMID:15910595
Abstract

AIMS

To devise clinically applicable methods for assessing p53 and Ki67 immunohistochemical (IHC) reactivity in Barrett's oesophagus (BE) and to compare the interobserver agreement between these methods and routine haematoxylin and eosin (H&E) evaluation.

METHODS AND RESULTS

One hundred and fifteen biopsies diagnosed as BE, selected from the files of the University Hospital MAS, Malmo, were re-evaluated for dysplasia by three pathologists. For IHC analysis areas with the most prominent positivity were evaluated. The mean of p53+ epithelial nuclei/high-power field (HPF) was obtained by counting between 1 and 5 HPFs/biopsy. A proliferation quotient (PQ) was obtained by dividing the number of Ki67+ epithelial nuclei in the upper half by the lower half of the mucosa, using two HPFs. Mean kappa values were 0.24, 0.71 and 0.52 for H&E, p53 and Ki67 evaluations, respectively. There was a correlation between increasing severity of dysplasia, IHC measurable overexpression of p53 and shift of the mucosal proliferation zone towards the surface, measured as PQ.

CONCLUSIONS

The described methods for p53 and Ki67 evaluation are more reproducible than routine H&E evaluation of BE. Furthermore, the IHC methods correlate with the severity of dysplasia and are useful supplementary prognostic markers.

摘要

目的

设计临床适用的方法来评估巴雷特食管(BE)中p53和Ki67免疫组化(IHC)反应性,并比较这些方法与常规苏木精和伊红(H&E)评估之间的观察者间一致性。

方法与结果

从马尔默大学医院MAS的档案中选取115例诊断为BE的活检标本,由三位病理学家重新评估发育异常情况。对于IHC分析,评估阳性最显著的区域。通过对每份活检标本计数1至5个高倍视野(HPF)来获得p53 +上皮细胞核/高倍视野(HPF)的平均值。使用两个高倍视野,通过将黏膜上半部分Ki67 +上皮细胞核的数量除以下半部分的数量来获得增殖指数(PQ)。H&E、p53和Ki67评估的平均kappa值分别为0.24、0.71和0.52。发育异常严重程度增加、IHC可测量的p53过表达与黏膜增殖区向表面的移位(以PQ衡量)之间存在相关性。

结论

所描述的p53和Ki67评估方法比BE的常规H&E评估更具可重复性。此外,IHC方法与发育异常的严重程度相关,是有用的辅助预后标志物。

相似文献

1
Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus.Ki67和p53免疫组织化学减少了观察者间在巴雷特食管评估中的差异。
Histopathology. 2005 Jun;46(6):642-8. doi: 10.1111/j.1365-2559.2005.02139.x.
2
Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus.用于巴雷特食管监测活检中发育异常分级的计算机化定量病理学
J Pathol. 2000 Feb;190(2):177-83. doi: 10.1002/(SICI)1096-9896(200002)190:2<177::AID-PATH508>3.0.CO;2-X.
3
p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression.巴雷特食管低度发育异常中p53的表达:与观察者间一致性及疾病进展的相关性
Am J Gastroenterol. 2002 Oct;97(10):2508-13. doi: 10.1111/j.1572-0241.2002.06032.x.
4
Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry.巴雷特异型增生与维也纳分类:可重复性、进展预测以及共识报告和p53免疫组化的影响
Histopathology. 2009 May;54(6):699-712. doi: 10.1111/j.1365-2559.2009.03288.x.
5
Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.非整倍体以及Ki67和p53的过表达作为巴雷特食管肿瘤进展的标志物:一项病例对照研究。
Am J Gastroenterol. 2009 Nov;104(11):2673-80. doi: 10.1038/ajg.2009.437. Epub 2009 Jul 28.
6
Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation.巴雷特食管的临床决策可以通过对与增殖和分化相关特征的计算机免疫定量分析和形态测量来辅助。
J Pathol. 1998 Feb;184(2):161-8. doi: 10.1002/(SICI)1096-9896(199802)184:2<161::AID-PATH971>3.0.CO;2-2.
7
Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining.数字化 Barrett 食管活检的 p53 免疫组化染色可改善诊断分层。
Histopathology. 2018 May;72(6):1015-1023. doi: 10.1111/his.13462. Epub 2018 Feb 28.
8
Photodynamic therapy of Barrett's esophagus: ablation of Barrett's mucosa and reduction in p53 protein expression after treatment.巴雷特食管的光动力疗法:治疗后巴雷特黏膜消融及p53蛋白表达降低
Anticancer Res. 2008 Jan-Feb;28(1B):485-9.
9
Dysplasia in Barrett's oesophagus: p53 immunostaining is more reproducible than haematoxylin and eosin diagnosis and improves overall reliability, while grading is poorly reproducible.巴雷特食管发育异常:p53免疫染色比苏木精和伊红染色诊断更具可重复性,提高了总体可靠性,而分级的可重复性较差。
Histopathology. 2016 Sep;69(3):431-40. doi: 10.1111/his.12956. Epub 2016 Apr 6.
10
Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies.在巴雷特食管预处理活检中,高级别异型增生和腺癌的鉴别存在观察者间一致性差的情况。
Am J Gastroenterol. 2008 Sep;103(9):2333-40; quiz 2341. doi: 10.1111/j.1572-0241.2008.02020.x. Epub 2008 Jul 30.

引用本文的文献

1
The Aberrant Expression of Biomarkers and Risk Prediction for Neoplastic Changes in Barrett's Esophagus-Dysplasia.生物标志物的异常表达与巴雷特食管发育异常肿瘤性变化的风险预测
Cancers (Basel). 2024 Jun 28;16(13):2386. doi: 10.3390/cancers16132386.
2
Identification of key potassium channel genes of temporal lobe epilepsy by bioinformatics analyses and experimental verification.通过生物信息学分析和实验验证鉴定颞叶癫痫的关键钾通道基因
Front Neurol. 2023 Jul 7;14:1175007. doi: 10.3389/fneur.2023.1175007. eCollection 2023.
3
A personalized and dynamic risk estimation model: The new paradigm in Barrett's esophagus surveillance.
个性化和动态风险评估模型:巴雷特食管监测的新模式。
PLoS One. 2022 Apr 27;17(4):e0267503. doi: 10.1371/journal.pone.0267503. eCollection 2022.
4
Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression.巴雷特食管:肿瘤进展的病理形态和分子遗传学关键。
Cancer Med. 2022 Jan;11(2):447-478. doi: 10.1002/cam4.4447. Epub 2021 Dec 6.
5
Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity.热休克蛋白70、谷氨酰胺合成酶和磷脂酰肌醇蛋白聚糖-3联合使用,对乙肝相关肝细胞癌具有较高的诊断特异性和敏感性。
Eur J Histochem. 2018 Jan 29;62(1):2859. doi: 10.4081/ejh.2018.2859.
6
Barrett's Esophagus: Emerging Knowledge and Management Strategies.巴雷特食管:新出现的知识与管理策略
Patholog Res Int. 2012;2012:814146. doi: 10.1155/2012/814146. Epub 2012 May 30.
7
Evidence for DNA damage checkpoint activation in barrett esophagus.巴雷特食管中 DNA 损伤检查点激活的证据。
Transl Oncol. 2010 Feb;3(1):33-42. doi: 10.1593/tlo.09187.
8
Defining Cancer Risk in Barrett's Esophagus: A Pathologist's Perspective.巴雷特食管癌症风险的界定:病理学家的观点
Gastrointest Cancer Res. 2008 Nov;2(6):308-10.
9
Diagnosis and grading of dysplasia in Barrett's oesophagus.巴雷特食管发育异常的诊断与分级
J Clin Pathol. 2006 Oct;59(10):1029-38. doi: 10.1136/jcp.2005.035337.